Michel Hasselmann

Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study

Bertrand Guidet, Olivier Martinet, Thierry Boulain et al. · Critical Care · 2012 · 342 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

L-alanyl-L-glutamine dipeptide–supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study*

Pierre Déchelotte, Michel Hasselmann, Luc Cynober et al. · Critical Care Medicine · 2006 · 328 citations

Medicine, Surgery, Nutritional Support In Critical Care +16

A randomized trial of supplemental parenteral nutrition in underweight and overweight critically ill patients: the TOP-UP pilot trial

Paul E. Wischmeyer, Michel Hasselmann, Christine Kummerlen et al. · Critical Care · 2017 · 156 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +17

Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study

Bertrand Guidet, Olivier Martinet, Thierry Boulain et al. · Critical Care · 2012 · 143 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Methylene blue increases systemic vascular resistance in human septic shock

Francis Schneider, Ph. Lutun, Michel Hasselmann et al. · Intensive Care Medicine · 1992 · 139 citations

Veterinary Medicine, Pharmacology, Physiology +12